Literature DB >> 8773400

The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow.

W W Lautt1.   

Abstract

Intrinsic regulation of hepatic blood flow is mediated only through the hepatic artery because the liver is not able to directly regulate portal vein blood flow. Hepatic metabolic activity does not affect hepatic artery flow. Although the hepatic artery is affected by sympathetic nerves and blood-borne agents, the intrinsic regulation of the hepatic artery can be demonstrated if these factors are controlled. The primary intrinsic regulator of the hepatic artery is the hepatic arterial buffer response, which is the inverse response of the hepatic artery to changes in portal vein flow. The hepatic arterial buffer response is sufficiently powerful that doubling portal vein flow leads to maximal constriction in the hepatic artery, while low portal vein flow can result in maximal dilation. The mechanism of the hepatic arterial buffer response is based on adenosine washout, whereby adenosine is produced at a constant rate, independent of oxygen supply or demand, and secreted into a small fluid compartment that surrounds the hepatic arterial resistance vessels. If portal vein flow decreases, less adenosine is washed away into the portal blood and the accumulated adenosine leads to hepatic arterial dilation. Similarly, hepatic arterial autoregulation operates by the same mechanism, whereby a decrease in arterial pressure leads to a decrease in hepatic arterial flow, thus resulting in less adenosine washout into the hepatic artery blood. The accumulated adenosine leads to hepatic artery dilation. These intrinsic regulatory mechanisms tend to maintain total hepatic blood flow at a constant level, thus stabilizing hepatic clearance of hormones, venous return, and cardiac output.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773400

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  20 in total

1.  Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after burn and sepsis.

Authors:  Tamer Tadros; Daniel L Traber; David N Herndon
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

Review 2.  [Small-for-size: experimental findings for liver surgery].

Authors:  C Eipel; K Abshagen; B Vollmar
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 3.  A critical appraisal of the hemodynamic signal driving liver regeneration.

Authors:  Kerstin Abshagen; Christian Eipel; Brigitte Vollmar
Journal:  Langenbecks Arch Surg       Date:  2012-02-07       Impact factor: 3.445

4.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

5.  Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis.

Authors:  Natalia Rush; Hongliu Sun; Yukihiro Nakanishi; Wadad Mneimneh; Paul Y Kwo; Romil Saxena
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

6.  Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt.

Authors:  Yasukazu Kako; Koichiro Yamakado; Wataru Jomoto; Toshiya Nasada; Koichiro Asada; Haruyuki Takaki; Kaoru Kobayashi; Takashi Daimon; Shozo Hirota
Journal:  Jpn J Radiol       Date:  2017-05-13       Impact factor: 2.374

Review 7.  SIRT of liver metastases: physiological and pathophysiological considerations.

Authors:  Christophe Van de Wiele; Alex Maes; Eddy Brugman; Yves D'Asseler; Bart De Spiegeleer; Gilles Mees; Karin Stellamans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

Review 8.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

Review 9.  [Cholestasis and liver dysfunction in critical care patients].

Authors:  M Kredel; J Brederlau; N Roewer; C Wunder
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

10.  Thoracic epidural anesthesia reverses sepsis-induced hepatic hyperperfusion and reduces leukocyte adhesion in septic rats.

Authors:  Hendrik Freise; Fritz Daudel; Christina Grosserichter; Stefan Lauer; Juergen Hinkelmann; Hugo K Van Aken; Andreas W Sielenkaemper; Martin Westphal; Lars G Fischer
Journal:  Crit Care       Date:  2009-07-13       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.